Skip to main content
. Author manuscript; available in PMC: 2021 Jul 30.
Published in final edited form as: IEEE J Biomed Health Inform. 2020 May 4;24(7):1952–1967. doi: 10.1109/JBHI.2020.2990797

TABLE III.

In this table, we provide our scenario results for treatment sequence length two. The first column represents the query ID. The second column shows the scenario path (middle age, female, breast cancer, and treatment sequence length two). In the second column, S means surgery, Cmeans chemotherapy, Rmeans radiation therapy, andHmeans hormone therapy. Here, treatment paths are mentioned in the ordered initial format. For example, S-Cmeans the patient first used surgery and then used chemotherapy. We present outcomes in the third column, which is divided into breast cancer subsites. The breast cancer subsite columns are further divided intoRC (right censored) andDE (deceased) columns. The “*” symbol meanswe can not report the value because of our data reporting restriction.” Empty table cell meansno value is available.”

Query ID Scenario Path Outcomes
C50.0 C50.1 C50.2 C50.3 C50.4 C50.5 C50.6 C50.8 C50.9
RC DE RC DE RC DE RC DE RC DE RC DE RC DE RC DE RC DE
Q2.1 S-C * * 100 41 249 64 138 35 820 263 164 42 20 * 502 153 365 152
Q2.2 S-R * * 156 19 338 53 159 17 1,014 121 217 24 21 * 547 63 361 53
Q2.3 S-H 16 * 116 * 180 16 99 * 483 45 117 * * * 357 35 277 32
Q2.4 C-S * 24 * 34 * 18 * 147 78 30 * * * 82 45 63 70
Q2.5 C-R * * * * * * * * * * * * * 23
Q2.6 C-H * * * * 17 * * * * * * * 17
Q2.7 R-S * * * * * * * * * * * 16 *
Q2.8 R-C * * * * * * * * 23
Q2.9 R-H * * * * * * *
Q2.10 H-S * * * * * * * 17 * * * * * 17 *
Q2.11 H-C * * * * * * * * * * *
Q2.12 H-R * * * * * *